https://www.selleckchem.com/pr....oducts/sgc-cbp30.htm
All healthy subjects showed lower intensity levels than the other diabetic counterparts (proliferative DR or nonproliferative DR patients), implying the potential of this device in clinical applications. Overall, the diagnostic device facilitates point-of-care-testing and provides a low-cost (~1 USD), compact, and reliable tool for early diagnosis in resource-limited areas.For the generation of representative volume elements a statistical description of the relevant parameters is necessary. These parameters usually describe the geomet
Curtir
Comentario
Compartilhar
